Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla(TM) Oncotype DX Genomic Prostate Score ® Test REDWOOD CITY, Calif., United States, and MECHELEN, Belgium, ...
A urological "smell" test for prostate cancer is snaking its way through the R&D process. The University of the West of England's Urological Institute team at Southmead Hospital and the Bristol Royal ...
PSA blood test IsoPSA can correctly rule out high-grade prostate cancer 93% of the time and thus has the potential to reduce the number of unnecessary prostate biopsies. The following article is part ...
It may be possible to identify men who could benefit from earlier therapy. Researchers have developed a new blood test that can distinguish severely symptomatic BPH from BPH that occurs with few if ...
A urological "smell" test for prostate cancer is snaking its way through the R&D process. The University of the West of England's Urological Institute team at Southmead Hospital and the Bristol Royal ...
CHATSWORTH, Calif., May 23, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), announced today that a poster of the results of a multi-center clinical study utilizing its proprietary ...
The Chosun Ilbo on MSN
PSA test excluded from national cancer screening program
After the government announced on the 24th a plan to raise the early diagnosis rate of the six major cancers—stomach, breast, cervical, liver, colorectal, and lung cancers—to 60% by 2030, medical ...
PRESS RELEASE: 3 December 2018, 22:30 CET/16:30 EST Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla(TM) Oncotype DX Genomic Prostate Score ® Test REDWOOD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results